Literature DB >> 19639273

Human invariant natural killer T cells: implications for immunotherapy.

Tsuyoshi Takahashi1, Mineo Kurokawa2.   

Abstract

Human invariant natural killer T cells are a unique lymphocyte population that have an invariant T-cell receptor and recognize glycolipids instead of peptides in the restriction of CD1d molecules. These natural killer T cells play important roles in anti-tumor immunity, transplantation immunity, allergy, autoimmunity and microbial immunity. Since human natural killer T cells show high-level biological activity such as cytokine production, an anti-tumor effect and regulatory T-cell control, they may be a useful tool in immune-cell therapy. In this review, we summarize the immune responses mediated by human natural killer T cells, especially in tumor and transplantation immunity, and discuss their potential in clinical applications.

Entities:  

Mesh:

Year:  2009        PMID: 19639273     DOI: 10.1007/s12185-009-0379-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  70 in total

Review 1.  NKT cells: what's in a name?

Authors:  Dale I Godfrey; H Robson MacDonald; Mitchell Kronenberg; Mark J Smyth; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

2.  Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells.

Authors:  T Takahashi; M Nieda; Y Koezuka; A Nicol; S A Porcelli; Y Ishikawa; K Tadokoro; H Hirai; T Juji
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

3.  CD1d-restricted NKT cells: an interstrain comparison.

Authors:  K J Hammond; D G Pellicci; L D Poulton; O V Naidenko; A A Scalzo; A G Baxter; D I Godfrey
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer.

Authors:  Shinichiro Motohashi; Aki Ishikawa; Eiichi Ishikawa; Mizuto Otsuji; Toshihiko Iizasa; Hideki Hanaoka; Naomi Shimizu; Shigetoshi Horiguchi; Yoshitaka Okamoto; Shin-ichiro Fujii; Masaru Taniguchi; Takehiko Fujisawa; Toshinori Nakayama
Journal:  Clin Cancer Res       Date:  2006-10-06       Impact factor: 12.531

5.  A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.

Authors:  M Tomura; W G Yu; H J Ahn; M Yamashita; Y F Yang; S Ono; T Hamaoka; T Kawano; M Taniguchi; Y Koezuka; H Fujiwara
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

6.  Protective conditioning for acute graft-versus-host disease.

Authors:  Robert Lowsky; Tsuyoshi Takahashi; Yin Ping Liu; Sussan Dejbakhsh-Jones; F Carl Grumet; Judith A Shizuru; Ginna G Laport; Keith E Stockerl-Goldstein; Laura J Johnston; Richard T Hoppe; Daniel A Bloch; Karl G Blume; Robert S Negrin; Samuel Strober
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

7.  Valpha24+ natural killer T-cell responses against T-acute lymphoblastic leukaemia cells: implications for immunotherapy.

Authors:  Tsuyoshi Takahashi; Kyoko Haraguchi; Shigeru Chiba; Masaki Yasukawa; Yoichi Shibata; Hisamaru Hirai
Journal:  Br J Haematol       Date:  2003-07       Impact factor: 6.998

8.  V alpha 24+ natural killer T cells are markedly decreased in atopic dermatitis patients.

Authors:  Tsuyoshi Takahashi; Koichiro Nakamura; Shigeru Chiba; Yoshinobu Kanda; Kunihiko Tamaki; Hisamaru Hirai
Journal:  Hum Immunol       Date:  2003-06       Impact factor: 2.850

9.  Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.

Authors:  David H Chang; Keren Osman; John Connolly; Anjli Kukreja; Joseph Krasovsky; Maggi Pack; Aisha Hutchinson; Matthew Geller; Nancy Liu; Rebecca Annable; Jennifer Shay; Kelly Kirchhoff; Nobusuke Nishi; Yoshitaka Ando; Kunihiko Hayashi; Hani Hassoun; Ralph M Steinman; Madhav V Dhodapkar
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

10.  Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain.

Authors:  S Porcelli; C E Yockey; M B Brenner; S P Balk
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.